Alphabet Shuts Down Verily’s Medical Device Program to Double Down on AI
Verily Exits the Devices Market
Alphabet’s health-focused subsidiary, Verily, has announced the closure of its entire medical device division, a move that comes with staff layoffs. CEO Stephen Gillett confirmed the decision in an internal memo, describing it as a “difficult decision” but necessary for the company’s future direction, according to Business Insider.
“Over the years, Verily has built a legacy in developing world-class, innovative medical devices,” Gillett stated, while acknowledging that “the path forward requires difficult decisions” as the firm pivots toward artificial intelligence and data-driven healthcare solutions.
Alphabet’s Wider AI Strategy
This restructuring reflects Alphabet’s broader strategy of channeling more resources into artificial intelligence while scaling back on projects that don’t align directly with its AI-first focus. Over the past few years, Alphabet has repeatedly reduced costs, including workforce cuts in its HR and cloud divisions earlier in 2024. The company also introduced voluntary exit programs for its 25,000-strong Platforms & Devices unit, signaling a push to streamline operations.
The most significant layoffs occurred in January 2023, when Alphabet eliminated 12,000 positions, roughly 6% of its global workforce, in anticipation of an economic slowdown.
AI at the Center of Tech Industry Priorities
The timing of Alphabet’s shift coincides with the explosive rise of generative AI. In January 2023, ChatGPT became the fastest-growing consumer software in history, attracting more than 100 million users in just two months. This milestone set off a wave of investment and competitive activity across the tech sector, with AI becoming the central driver of innovation and strategy.
Conclusion
Verily’s exit from medical devices underscores a significant turning point: Alphabet is no longer just experimenting across different technologies but is now prioritizing AI as its long-term growth engine. As the global race for AI dominance accelerates, this decision highlights how even established projects within Alphabet are being reshaped to fit the company’s evolving strategy.
0 Comments